Literature DB >> 30256094

DRONE: Direct Tracking of DNA Cytidine Deamination and Other DNA Modifying Activities.

Tomoaki Sasaki1, Shalley N Kudalkar1, Nicole Bertoletti1, Karen S Anderson1.   

Abstract

Enzymes that catalyze DNA modifying activities including cytidine deamination and cytosine methylation play important biological roles and have been implicated pathologically in diseases such as cancer. Here, we report Direct Resolution of ONE dalton difference (DRONE), an ultra high performance liquid chromatography (UHPLC)-based analytical method to track a single dalton change in the cytosine-to-uracil conversion catalyzed by the human apolipoprotein B m-RNA editing catalytic polypeptide-like 3 (APOBEC3) cytidine deaminases, implicated in cancer and antiviral defense. Additionally, we demonstrate broad applicability by tracking other important DNA modifications and assessing epigenetic enzyme inhibition. We have extended our methodology to obtain data on two distinct deamination events in the same oligonucleotide substrate designed from a putative APOBEC substrate, diversifying the utility of the described method. DRONE provides an important foundation for in-depth analysis of DNA-modifying enzymes and versatile detection of novel DNA modifications of interest.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30256094      PMCID: PMC6410358          DOI: 10.1021/acs.analchem.8b01405

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  38 in total

1.  APOBEC3G DNA deaminase acts processively 3' --> 5' on single-stranded DNA.

Authors:  Linda Chelico; Phuong Pham; Peter Calabrese; Myron F Goodman
Journal:  Nat Struct Mol Biol       Date:  2006-04-23       Impact factor: 15.369

2.  Measuring editing activity and identifying cytidine-to-uridine mRNA editing factors in cells and biochemical isolates.

Authors:  Harold C Smith
Journal:  Methods Enzymol       Date:  2007       Impact factor: 1.600

3.  An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.

Authors:  Steven A Roberts; Michael S Lawrence; Leszek J Klimczak; Sara A Grimm; David Fargo; Petar Stojanov; Adam Kiezun; Gregory V Kryukov; Scott L Carter; Gordon Saksena; Shawn Harris; Ruchir R Shah; Michael A Resnick; Gad Getz; Dmitry A Gordenin
Journal:  Nat Genet       Date:  2013-07-14       Impact factor: 38.330

4.  Direct evidence that RNA inhibits APOBEC3G ssDNA cytidine deaminase activity.

Authors:  William M McDougall; Harold C Smith
Journal:  Biochem Biophys Res Commun       Date:  2011-08-11       Impact factor: 3.575

5.  An in vitro system for the editing of apolipoprotein B mRNA.

Authors:  D M Driscoll; J K Wynne; S C Wallis; J Scott
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

Review 6.  Targeting DNA repair pathways for cancer treatment: what's new?

Authors:  Mark R Kelley; Derek Logsdon; Melissa L Fishel
Journal:  Future Oncol       Date:  2014-05       Impact factor: 3.404

7.  APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication.

Authors:  Vladimir B Seplyarskiy; Ruslan A Soldatov; Konstantin Y Popadin; Stylianos E Antonarakis; Georgii A Bazykin; Sergey I Nikolaev
Journal:  Genome Res       Date:  2016-01-11       Impact factor: 9.043

8.  An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers.

Authors:  Kin Chan; Steven A Roberts; Leszek J Klimczak; Joan F Sterling; Natalie Saini; Ewa P Malc; Jaegil Kim; David J Kwiatkowski; David C Fargo; Piotr A Mieczkowski; Gad Getz; Dmitry A Gordenin
Journal:  Nat Genet       Date:  2015-08-10       Impact factor: 38.330

Review 9.  DNA methyltransferases: a novel target for prevention and therapy.

Authors:  Dharmalingam Subramaniam; Ravi Thombre; Animesh Dhar; Shrikant Anant
Journal:  Front Oncol       Date:  2014-05-01       Impact factor: 6.244

Review 10.  Role of TET enzymes in DNA methylation, development, and cancer.

Authors:  Kasper Dindler Rasmussen; Kristian Helin
Journal:  Genes Dev       Date:  2016-04-01       Impact factor: 11.361

View more
  2 in total

1.  Structure-Guided Identification of DNMT3B Inhibitors.

Authors:  Ana S Newton; John C Faver; Goran Micevic; Viswanathan Muthusamy; Shalley N Kudalkar; Nicole Bertoletti; Karen S Anderson; Marcus W Bosenberg; William L Jorgensen
Journal:  ACS Med Chem Lett       Date:  2020-02-07       Impact factor: 4.345

Review 2.  The current toolbox for APOBEC drug discovery.

Authors:  Michael J Grillo; Katherine F M Jones; Michael A Carpenter; Reuben S Harris; Daniel A Harki
Journal:  Trends Pharmacol Sci       Date:  2022-05       Impact factor: 17.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.